| Name | Title | Contact Details |
|---|
Semler Scientific, Inc. is an emerging medical risk-assessment company whose diagnostic and testing products and services help to guide patient care and close the gap between cost of care and compensation for care.
Contego Medical, founded in 2005, has developed a family of novel emboli protection devices. The main feature of each device is that the treatment portion (i.e., balloon or stent) is on the same catheter as the embolic protection device, thus coupling the two together. This device can act as an angioplasty balloon with an integrated emboli protection device. If a stent is mounted on the balloon, it can serve as a stent with an integrated emboli protection device. We know that embolization occurs with all angioplasty and stenting procedures. It is usually hard to predict which ones will result in clinical sequalae. Despite knowing that embolization is ubiquitous, embolic protection devices are not used in all procedures as they add complexity, time, and cost. Dedicated devices do not exist for renal intervention, although the majority of physicians say they would use one if it existed. Contego Medical’s family of embolic protection devices represent a paradigm shift in the treatment of cardiovascular disease.
Sophion Bioscience is a North Brunswick, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
We work to improve the well-being of individuals and families by delivering quality, comprehensive physical and behavioral healthcare services. We coordinate services for the needs of all who seek care, regardless of socioeconomic status. We partner for creative solutions to meet the diverse needs of individuals, families and communities.
PTW New York Corporation is a Hicksville, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.